{"id":"https://openalex.org/W7124298470","doi":"https://doi.org/10.5281/zenodo.18255111","title":"FORMULATION, CHARACTERIZATION AND EVALUATION OF SOLID DISPERSION FOR CNS DRUG LOADED IN TRANSDERMAL PATCH","display_name":"FORMULATION, CHARACTERIZATION AND EVALUATION OF SOLID DISPERSION FOR CNS DRUG LOADED IN TRANSDERMAL PATCH","publication_year":2026,"publication_date":"2026-01-16","ids":{"openalex":"https://openalex.org/W7124298470","doi":"https://doi.org/10.5281/zenodo.18255111"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.18255111","doi":"https://doi.org/10.5281/zenodo.18255111","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.18255111","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.18255111","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5123163604","display_name":"Rajashree Gude1*, Eliska D'Souza2, Akshata Shirodker3, Raunak Rai4","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rajashree Gude1*, Eliska D'Souza2, Akshata Shirodker3, Raunak Rai4","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5123163604"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02164119,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.18639999628067017,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bromocriptine-mesylate","display_name":"bromocriptine mesylate","score":0.996999979019165},{"id":"https://openalex.org/keywords/solid-dispersion","display_name":"solid dispersion","score":0.9129999876022339},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.9879999756813049},{"id":"https://openalex.org/keywords/matrix-type-patch","display_name":"matrix-type patch","score":0.7459999918937683},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hydroxypropyl-cellulose","display_name":"hydroxypropyl cellulose","score":0.9729999899864197},{"id":"https://openalex.org/keywords/kneading-method","display_name":"kneading method","score":0.7369999885559082},{"id":"https://openalex.org/keywords/solvent-evaporation","display_name":"solvent evaporation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/bcs-class-ii-drugs","display_name":"BCS class II drugs","score":0.7450000047683716},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.7289999723434448},{"id":"https://openalex.org/keywords/ex-vivo-skin-permeation","display_name":"ex vivo skin permeation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.7020000219345093},{"id":"https://openalex.org/keywords/full-factorial-design","display_name":"full factorial design","score":0.5299999713897705},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.8080999851226807},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6521000266075134},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5996999740600586},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5924999713897705},{"id":"https://openalex.org/C2777937549","wikidata":"https://www.wikidata.org/wiki/Q5464303","display_name":"Folding endurance","level":4,"score":0.571399986743927},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.5539000034332275},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5516999959945679},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.5335000157356262},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.48899999260902405},{"id":"https://openalex.org/C2778551929","wikidata":"https://www.wikidata.org/wiki/Q146339","display_name":"Polyvinyl alcohol","level":2,"score":0.4375},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.42320001125335693},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.415800005197525},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.3984000086784363},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.38609999418258667},{"id":"https://openalex.org/C106487976","wikidata":"https://www.wikidata.org/wiki/Q685816","display_name":"Matrix (chemical analysis)","level":2,"score":0.36250001192092896},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.3450999855995178},{"id":"https://openalex.org/C2776035855","wikidata":"https://www.wikidata.org/wiki/Q420113","display_name":"Ethyl cellulose","level":3,"score":0.3395000100135803},{"id":"https://openalex.org/C2776174307","wikidata":"https://www.wikidata.org/wiki/Q416312","display_name":"Methyl cellulose","level":3,"score":0.3393999934196472},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.337799996137619},{"id":"https://openalex.org/C69357855","wikidata":"https://www.wikidata.org/wiki/Q163214","display_name":"Diffusion","level":2,"score":0.32760000228881836},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.32429999113082886},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.2994999885559082},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29420000314712524},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2906000018119812},{"id":"https://openalex.org/C2779783494","wikidata":"https://www.wikidata.org/wiki/Q416222","display_name":"Isopropyl myristate","level":2,"score":0.2883000075817108},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2824999988079071},{"id":"https://openalex.org/C2779251873","wikidata":"https://www.wikidata.org/wiki/Q80294","display_name":"Cellulose","level":2,"score":0.27709999680519104},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.27410000562667847},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.27399998903274536},{"id":"https://openalex.org/C84199377","wikidata":"https://www.wikidata.org/wiki/Q723912","display_name":"Freeze-drying","level":2,"score":0.26579999923706055},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.2639999985694885},{"id":"https://openalex.org/C2780161600","wikidata":"https://www.wikidata.org/wiki/Q153","display_name":"Ethanol","level":2,"score":0.258899986743927},{"id":"https://openalex.org/C67558686","wikidata":"https://www.wikidata.org/wiki/Q1770806","display_name":"Molding (decorative)","level":2,"score":0.2556999921798706}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.18255111","doi":"https://doi.org/10.5281/zenodo.18255111","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.18255111","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.18255112","doi":"https://doi.org/10.5281/zenodo.18255112","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.18255112","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.18255111","doi":"https://doi.org/10.5281/zenodo.18255111","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.18255111","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Bromocriptine":[0],"Mesylate":[1],"(BM)":[2],"solid":[3],"dispersion":[4],"(SD)":[5],"was":[6,37,60,120,152,172,206],"formulated":[7],"and":[8,16,31,35,47,55,67,109,129,154,158,180,199,222],"loaded":[9],"into":[10],"matrix":[11],"type":[12],"transdermal":[13,177,204],"patch,":[14],"optimized":[15,176],"characterized.":[17],"BM,":[18],"an":[19],"anti-Parkinson\u2019s":[20],"agent,":[21],"belonging":[22],"to":[23],"BCS":[24],"Class":[25],"II,":[26],"has":[27],"low":[28],"aqueous":[29],"solubility":[30],"high":[32],"permeability.":[33],"Solubility":[34],"bioavailability":[36],"enhanced":[38],"by":[39,52,75],"SDs":[40],"using":[41,78,142],"Hydroxy":[42,48],"propyl":[43,49],"beta":[44],"cyclodextrin":[45],"(HP-b-C)":[46],"cellulose":[50],"(HPC),":[51],"Solvent":[53],"evaporation":[54],"Kneading":[56],"method.":[57],"The":[58,72],"SD":[59,73],"selected":[61,133,162],"based":[62],"on":[63,167],"%yield,":[64],"%drug":[65,186],"content":[66,103],"in":[68,83,110,115],"vitro":[69,111],"dissolution":[70,211],"data.":[71],"prepared":[74],"kneading":[76],"method":[77],"combination":[79],"of":[80,88,97,104,123,139,214],"2":[81],"carriers":[82],"a":[84,170],"drug":[85,102],"carrier":[86],"ratio":[87],"1:":[89],"0.5":[90],":3":[91],"(F4),":[92],"exhibited":[93],"highest":[94],"percentage":[95,101],"yield":[96],"97.640":[98],"\u00b1":[99,106],"0.7692%,":[100],"98.770":[105],"0.8129":[107],"%":[108,114],"release":[112],"98.85":[113],"60":[116],"mins.":[117],"Hence,":[118],"F4":[119],"used.":[121],"Concentration":[122],"HPMC":[124],"K4M,":[125],"Eudragit":[126],"RL":[127],"100":[128],"Propylene":[130],"glycol":[131],"were":[132,161],"as":[134,163],"independent":[135],"variables":[136],"for":[137,149,174,182,224],"design":[138],"experiment":[140],"(DoE)":[141],"23":[143],"Full":[144],"factorial":[145],"design.":[146],"A":[147],"formula":[148,171],"8":[150],"runs":[151],"generated,":[153],"formulated.":[155],"Diffusion":[156],"study":[157,198],"folding":[159,189],"endurance":[160],"dependent":[164],"variables.":[165],"Based":[166],"response":[168],"data,":[169],"generated":[173],"the":[175],"patch":[178,205],"(E9)":[179],"evaluated":[181],"thickness,":[183],"weight":[184],"variation,":[185],"content,":[187],"%elongation,":[188],"endurance,":[190],"surface":[191],"pH,":[192],"in-vitro":[193],"diffusion":[194],"study,":[195],"ex-vivo":[196],"permeation":[197],"skin":[200],"irritancy":[201],"study.":[202],"BM-SD":[203],"successfully":[207],"developed":[208],"with":[209],"improved":[210,218],"profile,":[212],"avoidance":[213],"extensive":[215],"first-pass":[216],"metabolism,":[217],"patient":[219],"compliance,":[220],"effective":[221],"safe":[223],"use.":[225]},"counts_by_year":[],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2026-01-16T00:00:00"}